Support for LAist comes from
We Explain L.A.
Stay Connected

Share This


An RSV Vaccine For Babies Could Be Coming Soon

A covered syringe rests on a table, pointing to the right.
A vaccine syringe sits on a table.
(Mario Tama
Getty Images)
Support your source for local news!
Today, put a dollar value on the trustworthy reporting you rely on all year long. The local news you read here every day is crafted for you, but right now, we need your help to keep it going. In these uncertain times, your support is even more important. We can't hold those in power accountable and uplift voices from the community without your partnership. Thank you.


A new shot could soon be available to protect babies from RSV, a highly contagious respiratory disease.

What will the shot do? It’s a monoclonal antibody that can both prevent and treat infections in infants who have already been diagnosed with RSV. Dr. Kimberly Shriner, infectious disease specialist at Huntington Hospital, told our newsroom’s AirTalk program the development is “very important,” as RSV was recently responsible for a surge in hospitalizations in the U.S. among infants and small children.

“The huge number of children that were getting RSV speaks to the importance of vigilance,” said Shriner, “and the need for developing effective therapies and preventative measures, including vaccines and antibiotic therapy.”

Support for LAist comes from

What’s the next step for the shot? The single dose antibody, known as Nirsevimab, still needs FDA approval. That could happen later this summer, making the drug available for babies up to 24 months old.

Most Read